197 related articles for article (PubMed ID: 30018796)
1. Haematopoietic stem cell transplantation in systemic sclerosis.
Walker UA; Saketkoo LA; Distler O
RMD Open; 2018; 4(1):e000533. PubMed ID: 30018796
[TBL] [Abstract][Full Text] [Related]
2. Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis.
Burt RK; Oliveira MC; Shah SJ; Moraes DA; Simoes B; Gheorghiade M; Schroeder J; Ruderman E; Farge D; Chai ZJ; Marjanovic Z; Jain S; Morgan A; Milanetti F; Han X; Jovanovic B; Helenowski IB; Voltarelli J
Lancet; 2013 Mar; 381(9872):1116-24. PubMed ID: 23363664
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis.
Vonk MC; Marjanovic Z; van den Hoogen FH; Zohar S; Schattenberg AV; Fibbe WE; Larghero J; Gluckman E; Preijers FW; van Dijk AP; Bax JJ; Roblot P; van Riel PL; van Laar JM; Farge D
Ann Rheum Dis; 2008 Jan; 67(1):98-104. PubMed ID: 17526554
[TBL] [Abstract][Full Text] [Related]
4. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial.
Burt RK; Shah SJ; Dill K; Grant T; Gheorghiade M; Schroeder J; Craig R; Hirano I; Marshall K; Ruderman E; Jovanovic B; Milanetti F; Jain S; Boyce K; Morgan A; Carr J; Barr W
Lancet; 2011 Aug; 378(9790):498-506. PubMed ID: 21777972
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors for treatment-related mortality and major adverse events after autologous haematopoietic stem cell transplantation for systemic sclerosis: results of a long-term follow-up multicentre study.
van Bijnen S; de Vries-Bouwstra J; van den Ende CH; Boonstra M; Kroft L; Geurts B; Snoeren M; Schouffoer A; Spierings J; van Laar JM; Huizinga TW; Voskuyl A; Marijt E; van der Velden W; van den Hoogen FH; Vonk MC
Ann Rheum Dis; 2020 Aug; 79(8):1084-1089. PubMed ID: 32409324
[TBL] [Abstract][Full Text] [Related]
6. Autologous stem cell transplantation for systemic sclerosis.
Farge D; Nash R; Laar JM
Autoimmunity; 2008 Dec; 41(8):616-24. PubMed ID: 18958754
[TBL] [Abstract][Full Text] [Related]
7. Haematopoietic stem cell transplantation for poor-prognosis systemic sclerosis.
van Laar JM; Naraghi K; Tyndall A
Rheumatology (Oxford); 2015 Dec; 54(12):2126-33. PubMed ID: 25953700
[TBL] [Abstract][Full Text] [Related]
8. Update on stem cell transplantation for systemic sclerosis: recent trial results.
Naraghi K; van Laar JM
Curr Rheumatol Rep; 2013 May; 15(5):326. PubMed ID: 23516015
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic stem cell transplantation for systemic sclerosis: history and current status.
Burt RK; Milanetti F
Curr Opin Rheumatol; 2011 Nov; 23(6):519-29. PubMed ID: 21857226
[TBL] [Abstract][Full Text] [Related]
10. Autologous hematopoietic stem cell transplantation for systemic sclerosis.
Milanetti F; Bucha J; Testori A; Burt RK
Curr Stem Cell Res Ther; 2011 Mar; 6(1):16-28. PubMed ID: 20955159
[TBL] [Abstract][Full Text] [Related]
11. Haematopoietic stem cell transplantation for autoimmune diseases.
Swart JF; Delemarre EM; van Wijk F; Boelens JJ; Kuball J; van Laar JM; Wulffraat NM
Nat Rev Rheumatol; 2017 Apr; 13(4):244-256. PubMed ID: 28228650
[TBL] [Abstract][Full Text] [Related]
12. Autologous hematopoietic stem cell transplant for progressive diffuse systemic sclerosis: procedural success and clinical outcome in 5-year follow-up.
Pawlak-Buś K; Schmidt W; Olejarz M; Czyż A; Komarnicki M; Leszczyński P
Reumatologia; 2019; 57(1):50-54. PubMed ID: 30858631
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of conventionally-treated systemic sclerosis patients eligible for autologous haematopoietic stem cell transplantation.
Panopoulos ST; Tektonidou MG; Bournia VK; Laskari K; Sfikakis PP
Clin Exp Rheumatol; 2021; 39 Suppl 131(4):29-33. PubMed ID: 33200737
[TBL] [Abstract][Full Text] [Related]
14. [Autologous hematopoietic stem cell transplantation for systemic sclerosis : Position statement of the stem cell therapy working party of the German Society of Rheumatology].
Alexander T; Henes J; Distler JHW; Schmalzing M; Blank N; Kötter I; Hiepe F
Z Rheumatol; 2020 Jun; 79(5):429-436. PubMed ID: 32322977
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Rapidly Progressive Systemic Sclerosis: Current and Futures Perspectives.
Mendoza FA; Mansoor M; Jimenez SA
Expert Opin Orphan Drugs; 2016; 4(1):31-47. PubMed ID: 27812432
[TBL] [Abstract][Full Text] [Related]
16. Haematopoietic stem cell transplantation for autoimmune disorders.
Saccardi R; Di Gioia M; Bosi A
Curr Opin Hematol; 2008 Nov; 15(6):594-600. PubMed ID: 18832930
[TBL] [Abstract][Full Text] [Related]
17. Stem cell transplantation and mesenchymal cells to treat autoimmune diseases.
Tyndall A; van Laar JM
Presse Med; 2016 Jun; 45(6 Pt 2):e159-69. PubMed ID: 27256975
[TBL] [Abstract][Full Text] [Related]
18. Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions.
Tyndall A; Saccardi R
Clin Exp Immunol; 2005 Jul; 141(1):1-9. PubMed ID: 15958063
[TBL] [Abstract][Full Text] [Related]
19. The role of autologous haemopoietic stem cell transplantation in the treatment of autoimmune disorders.
Rebeiro P; Moore J
Intern Med J; 2016 Jan; 46(1):17-28. PubMed ID: 26524106
[TBL] [Abstract][Full Text] [Related]
20. Autologous hematopoietic stem cell transplantation in autoimmune diseases.
Annaloro C; Onida F; Lambertenghi Deliliers G
Expert Rev Hematol; 2009 Dec; 2(6):699-715. PubMed ID: 21082959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
